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Abstract
This study describes the role of two STAT6 gene variants in food allergy using data of
patients and their parents who underwent double-blind placebo-controlled food chal-
lenges (DBPCFCs). After quality control, 369 trios were analysed including 262 chil-
dren (71.0%) with food allergy. Associations were tested by the Family based
association test. The A alleles of both SNPs were associated with food allergy
(P = .036 and P = .013 for rs324015 and rs1059513, respectively). Furthermore,
these A alleles were associated with peanut allergy, higher sIgE levels to both peanut
and cow’s milk, more severe symptoms and higher eliciting doses during peanut and
cow’s milk DBPCFCs (all P < .05). In silico analysis indicates that the identified risk
variants increase STAT6 expression which stimulates the differentiation of CD4 + T
cells to the Th2 subset. In conclusion, STAT6 variants may be involved in the patho-
physiology of food allergy and their role seems to be independent of the allergenic
food.
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1 | INTRODUCTION
Multiple studies have provided evidence that food allergy is partly
genetically determined.1 One potentially important but less well-stu-
died gene in this context is signal transducer and activator of tran-
scription 6 (STAT6), which stimulates the differentiation of na€ıve
CD4 + T cells to the Th2 subset.2 Two SNPs within STAT6 have
been reported to be associated with IgE concentrations3-6 and sensi-
tization to foods,7 a history of nut allergy8 and persistence of cow’s
milk allergy(CMA).9 These last studies were based on a history of
nut allergy or open food challenges for cow’s milk allergy, both
known to have high false-positive rates. Therefore, we used the dou-
ble-blind placebo-controlled food challenge (DBPCFC), the gold stan-
dard, to investigate the genetics of food allergy. This study aimed to
investigate the association of two selected SNPs in STAT6, rs324015
and rs1059513, with food allergy defined by any positive DBPCFC.
In two subgroups of children who had a DBPCFC for the two most
frequently tested allergenic foods (peanut or cow’s milk), we studied
the association with (i) peanut and CMA; (ii) peanut or cow’s milk-
specific IgE (sIgE); (iii) the dose sensitivity to the tested food; and (iv)
the severity of the food-allergic reaction during the DBPCFC.
2 | METHODS
The GENEVA cohort included 421 trios (parents and child) in which
the child had a DBPCFC as part of regular tertiary paediatric allergy
care because of a history consistent with an IgE-mediated reaction
after ingestion of a food. A subgroup of the GENEVA cohort was
described previously.10,11 Recruitment took place at the University
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Medical Center Groningen from 2005 onwards. This study was ethi-
cally approved (METc 2004-146), and written informed (parental)
consent was obtained.
All DBPCFCs with positive or negative results were included. The
DBPCFCs were performed as previously described,12 and sIgE for
foods tested in DBPCFC was measured by CAP-FEIA (ImmunoDiag-
nostics, Uppsala, Sweden). A severity score was calculated based on
symptoms registered on the active day of positive DBPCFCs ranging
from 0 to 12 with 1 point for skin symptoms, 2 points for gastroin-
testinal symptoms and 3 points for upper airway, lower airway and/
or cardiovascular/neurological symptoms.13 The eliciting dose was
defined as the last dose in milligrams of protein of the allergenic food
ingested by the patient on the active day of a positive DBPCFC.
The two SNPs were selected because these had previously been
associated with sensitization to food or a history of food allergy3–8.
DNA was extracted from buccal swabs, saliva (Oragene Saliva Self-
Collection Kits OG-575 DNA-Genotek, Ottawa, Canada) or EDTA
blood (DNA Investigator Kit, Qiagen, Venlo, the Netherlands). Geno-
typing was performed by competitive allele-specific PCR by LGC
Genomics (LGC, Teddington, UK).
Associations were tested by the family-based association test
(FBAT 2.0.4 using the additive model14) which is robust to population
stratification and tests for Mendelian errors. The FBAT is based on
the transmission disequilibrium test which compares the alleles trans-
mitted to affected offspring with the expected distribution of alleles
among offspring. We did not apply correction for multiple testing as
these data reflect a validation of previously identified associations.
However, we tested in a two-tailed approach as literature reported
conflicting direction of effects. Linkage disequilibrium (LD) between
the studied variants and Hardy-Weinberg equilibrium was calculated
using Haploview 4.2.15 Trios were excluded when (i) the outcome of
the DBPCFC was inconclusive (n = 18); (ii) ≥2 Mendelian errors were
detected (n = 6) or (iii) when one of the members of the trio had a
call rate lower than an arbitrary cut-off of 50% (n = 28, the latter
two criteria included data of previously published gene variants10,11).
The functional consequences and LD patterns were checked in
the Finnish and British population using 1000 genomes phase 3 via
ensembl.org16 (r2 threshold .8). Expression quantitative trait loci
(eQTL) characteristics were studied by genenetwork.nl/bloodeqtl-
browser,17 and expression and genomic annotation was studied in
the online Haploreg18 and GTEx project19 databases.
3 | RESULTS
Of the 369 children, 14.1% of the DNA was extracted from blood.
Call rates and HWE P -values were 98.9% and 0.57 for rs324015,
and 98.2% and 0.94 for rs1059513, respectively. Allele frequencies
(AF) of both risk alleles were concordant with literature (AF of minor
allele A of rs324015 = 0.26 with reported AF = 0.31,8 0.24-0.2920;
AF of major allele A of rs1059513 = 0.91 with reported AF = 0.91,3
0.93-0.9220). The two SNPs were independent (R2 = .03,
D’ = 1.00).15
Of all children, 262 (71.0%) had at least one positive DBPCFC
and were thereby defined as having food allergy. Baseline character-
istics are shown in Table 1, and genetic association results with a
P < .10 are shown in Table 2. The A alleles of both SNPs were sig-
nificantly associated with being allergic to at least one food. In the
subgroup of 205 children tested for peanut, both A alleles were
associated with peanut allergy, higher sIgE levels to peanut and more
severe symptoms and greater eliciting doses during the peanut
DBPCFC. In the subgroup of 117 children tested for CMA, the A
allele of rs324015 was significantly associated with higher sIgE levels
to cow’s milk and the A allele of rs1059513 was significantly associ-
ated with more severe symptoms and greater eliciting doses during
the cow’s milk DBPCFC.
Of both SNPs, only rs1059513 is in LD with another variant,
rs3024971 (R2 = 1.0).16 Both genotyped SNPs are localized in the 30
untranslated region of STAT6,16 compatible with a role in post-tran-
scriptional gene expression by influencing polyadenylation, translation
efficiency and stability of mRNA.21 Locations of both rs324015 and
rs3024971 are characterized by enhancer histone marks in multiple
tissues which influence the accessibility to the transcriptional machin-
ery and can be modified by environmental exposures.18,22 Both geno-
typed SNPs and rs3024971 are listed in the eQTL browser as CIS-
eQTLs for STAT6 in peripheral blood in which the A alleles increase
expression of STAT6 (rs324015 minor allele A: Z-score 49.74,
P = 9.91E-198 and rs1059513 major allele A: Z-score 16.12,
P = 1.83E-58, rs3024971 major allele A: Z-score = 15.93, P = 4.03E-
57).17 Furthermore, rs324015 is described as a single-tissue eQTL in
oesophageal mucosa (effect size 0.20 for the A allele, P = 3.8E-7) and
STAT6 is highly expressed in whole blood, skin and small intestines.19
4 | DISCUSSION
We show for the first time that both A alleles of rs324015 and
rs1059513 are associated with food allergy and peanut allergy as
diagnosed by DBPCFCs, IgE sensitization to peanut and cow’s milk,
as well as more severe allergic reactions. We therefore conclude that
STAT6 genetic polymorphisms may be involved in the pathophysiol-
ogy of food allergy and their role seems to be independent of the
causal allergenic food.
In previous studies, the A allele of rs1059513 was described as a
risk variant, associated with asthma,23 atopic dermatitis,24 higher IgE
levels3,6 and sensitization to common food and inhalant allergens.7
The A allele of rs324015 was previously associated with an increased
risk for atopic asthma in a meta-analysis25 and with eosinophilia in
local inflammatory sites.4 In contrast, this A allele was also described
as the protective allele for nut allergy in 300 British subjects.8 Interest-
ingly, a gene-gene interaction between the A allele of rs324015 and
GT dinucleotide repeat polymorphisms in STAT6 exon 1 was reported
to influence the risk of any allergic disease in 168 Japanese subjects.26
Such a gene-gene interaction could explain these potentially conflict-
ing results, or they might be due to an as yet unidentified gene-envir-
onment interaction, similar to that previously described for CD14.27
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Such a gene-environment interaction is likely to be mediated by epige-
netic modifications.22 The functional consequences of the A allele of
rs324015 as presented in this article lend further credence to its role
as a risk variant for food allergy.
We show in peanut- and cow’s milk-allergic cases associations
between the A alleles of rs1059513 and rs324015 and a greater
eliciting dose. This implies that these A alleles are associated with
lower clinical sensitivity (allergic reaction at higher allergen dosages)
and that peanut-allergic subjects carrying these alleles are at lower
risk for allergic reactions. Interestingly, a higher eliciting dose was
previously associated with earlier resolution of peanut/tree nut
allergy and CMA.28 Therefore, our results are consistent with
another report describing the association between the A genotype in
rs324015 and an earlier age of developing tolerance for CMA.9
However, the A allele is the risk variant for having food allergy and
is associated with more severe food allergy. This confirms recent
insights regarding the independence of severity and dose sensitivity
in food allergy.29
Other STAT6 SNPs which are independent from the 2 SNPs
reported here (ie, rs167769, rs324011, rs12368672, rs2598483 and
TABLE 1 Descriptive statistics of the study population
DBPCFC confirmed food allergy
71.0% (n = 262)
DBPCFC confirmed tolerant
29.0% (n = 107) Total (n = 369)
Male, % (n) 56.9 (149) 61.7 (66) 58.3 (215)
Age in months at first DBPCFC, median, Q1-Q3a 78.0, 44.0-131.0 72.0, 34.5-135.0 76.0, 41.0-131.0
Number of foods tested in DBPCFC
Median, Q1-Q3a 2.0, 1.0-3.0 1.0, 1.0-1.0 1.0, 1.0-2.0
Any positive DBPCFCb % (n/n tested)
Peanut 75.8 (122/161) (0/44) 59.5 (122/205)
Cow’s milk 78.0 (64/82) (0/35) 54.7 (64/117)
Hen’s egg 62.9 (44/70) (0/20) 48.9 (44/90)
Hazelnut 56.5 (39/69) (0/6) 52.0 (39/75)
Cashew 93.0 (53/57) (0/7) 82.8 (53/64)
Walnut 87.0 (20/23) (0/6) 69.0 (20/29)
Soy 34.8 (8/23) (0/3) 30.8 (8/26)
Almond 9.1 (1/11) (0/2) 7.7 (1/13)
Wheat (0/4) (0/2) 0 (0/6)
Lupine seed (0/3) (0/2) 0 (0/5)
Pistachio (0/1) (0/2) 0 (0/3)
Sesame 100 (2/2) 100 (2/2)
Pine nut 100 (2/2) 100 (2/2)
Macadamia (0/1) (0/1) 0 (0/2)
Brazil nut 100 (1/1) 100 (1/1)
Atopic comorbidities % (n/n tested)
Atopic dermatitis 89.5 (230/257) 83.7 (87/104) 87.8 (317/361)
Asthma 58.5 (151/258) 48.5 (50/103) 55.7 (201/361)
Rhinoconjunctivitis 50.2 (127/253) 32.0 (32/100) 45.0 (159/353)
sIgEb (KU/L) median, Q1-Q3a (n)
Peanut 6.5, 2.0-40.0 (162) 2.0, 0.6-5.5 (43) 5.1, 1.3-24.9 (205)
Cow’s milk 5.2, 0.7-18.6 (83) 0.3, 0.3-0.7 (34) 1.9, 0.3-13.7 (117)
Severity of reactionb mean, SD (n)
Peanut 3.7, 2.3 (113)
Cow’s milk 3.5, 2.3 (61)
Eliciting doseb (mg protein) median, Q1-Q3a (n)
Peanut 69.9, 3.5-348.0 (109)
Cow’s milk 1750.0, 70.0-1750.0 (58)
DBPCFC, double-blind placebo-controlled food challenge; sIgE, specific IgE; SD, standard deviation; Q1-Q3, first and third quartile.
aVariables which were defined as not normally distributed after visual inspection of the Q-Q plot are presented by median and quartiles (Q1-Q3).
bWhen children had a DBPCFC for multiple foods, they are listed for each food-specific variable.
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rs703817) have been associated with other allergy-related pheno-
types such as total IgE, atopic dermatitis, eosinophilic esophagitis,
atopy or asthma.5,6,30-32 However, evidence on their association
with IgE-mediated food allergy was lacking. Therefore, these SNPs
were not included in our study, as our aim was to replicate and
validate SNPs previously associated with IgE-mediated food allergy.
We therefore cannot exclude that these other SNPs may also be
involved in (food) allergy and IgE production. We acknowledge that
most of our associations reach borderline significance and are not
corrected for multiple testing. More accurate phenotype definition
by use of the DBPCFC will have reduced the power requirement
somewhat, as was our experience with a similar study of the filag-
grin gene.29 Nevertheless, these results require replication to ascer-
tain whether these associations are truly independent of
sensitization to foods or atopic comorbidities and should thus be
confirmed in a larger study population with lower prevalences of
the latter conditions.
The A alleles of both SNPs are risk variants for food allergy, and
these A alleles are associated with higher expression of STAT6 in
several tissues.17,19 By inducing expression of GATA-3, STAT6
enhances expression of the Th2 cytokine genes IL-4, IL-5 and IL-13
which stimulates differentiation of na€ıve CD4+ T cells to the Th2
subset.2,22 These cytokines subsequently activate mast cells, macro-
phages and eosinophils to promote allergic responses. In activated B
cells, STAT6 promotes immunoglobulin class switching to IgE and
expression of antigen presenting cell surface molecules.2 To summa-
rize, STAT6 genetic polymorphisms may be involved in the patho-
physiology of food allergy and their role seems to be independent of
the causal allergenic food.
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